NTBLQ (Notable Labs) Inventories, Raw Materials & Components: $0.00 Mil (As of Jun. 2024)


What is Notable Labs Inventories, Raw Materials & Components?

Notable Labs NTBLQ -90.00% Inventories, Raw Materials & Components is $0.00 Mil as of Jun. 2024.

Notable Labs's inventories, raw materials & components for the quarter that ended in Jun. 2024 was $0.00 Mil.


Notable Labs Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Notable Labs's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Notable Labs Inventories, Raw Materials & Components Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
0.00 0.00 0.00

Notable Labs Quarterly Data
Dec21 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
Inventories, Raw Materials & Components Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Notable Labs Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $0.00 Mil mean?
Notable Labs (NTBLQ) has a Inventories, Raw Materials & Components of $0.00 Mil as of Jun. 2024. Raw materials are the components a company uses for its main products. View historical data on Notable Labs and its competitors.
Is Notable Labs' Inventories, Raw Materials & Components too high?
Notable Labs' current Inventories, Raw Materials & Components is $0.00 Mil.
How does Notable Labs' Inventories, Raw Materials & Components compare to VRTX and REGN?
Notable Labs' Inventories, Raw Materials & Components of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Notable Labs and its competitors. Notable Labs's current Inventories, Raw Materials & Components is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Notable Labs stock overvalued right now?
Notable Labs (NTBLQ) has a current Inventories, Raw Materials & Components of $0.00 Mil. The current Inventories, Raw Materials & Components is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Notable Labs (NTBLQ), the current Inventories, Raw Materials & Components is $0.00 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Notable Labs Business Description

Address 320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.